| 1 |
|
Permanent Activation of the Human P-glycoprotein by Covalent Modification of a Residue in the Drug-binding Site/
|
Loo, T. W
|
American Society for Biochemistry and Molecular Biology [etc.]
|
2003
|
|
|
|
| 2 |
|
Simultaneous Binding of Two Different Drugs in the Binding Pocket of the Human Multidrug Resistance P-glycoprotein/
|
Loo, T. W
|
American Society for Biochemistry and Molecular Biology [etc.]
|
2003
|
|
|
|
| 3 |
|
Substrate-induced Conformational Changes in the Transmembrane Segments of Human P-glycoprotein. DIRECT EVIDENCE FOR THE SUBSTRATE-INDUCED FIT MECHANISM FOR DRUG BINDING/
|
Loo, T. W
|
American Society for Biochemistry and Molecular Biology [etc.]
|
2003
|
|
|
|
| 4 |
|
Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators
|
Loo, T. W
|
American Society for Biochemistry and Molecular Biology [etc.]
|
1980
|
|
|
|
| 5 |
|
Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12
|
Loo, T. W
|
American Society for Biochemistry and Molecular Biology [etc.]
|
1980
|
|
|
|
| 6 |
|
Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate
|
Loo, T. W
|
American Society for Biochemistry and Molecular Biology [etc.]
|
1980
|
|
|
|
| 7 |
|
The minimum functional unit of human P-glycoprotein appears to be a monomer
|
Loo, T. W
|
American Society for Biochemistry and Molecular Biology [etc.]
|
1980
|
|
|
|
| 8 |
|
Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 inpredicted TM12 of human P-glycoprotein by drug substrates
|
Loo, T. W
|
American Society for Biochemistry and Molecular Biology [etc.]
|
1980
|
|
|
|
